ROYAL BANK OF CANADA - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 61 filers reported holding VOR BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q1 2024$2,000
-93.8%
870
-93.9%
0.00%
Q4 2023$32,000
+113.3%
14,271
+99.6%
0.00%
Q3 2023$15,000
+25.0%
7,149
+81.9%
0.00%
Q2 2023$12,000
+100.0%
3,931
+369.1%
0.00%
Q4 2022$6,0000.0%838
-46.7%
0.00%
Q3 2022$6,000
-14.3%
1,572
+34.8%
0.00%
Q1 2022$7,000
-84.1%
1,166
-69.5%
0.00%
Q4 2021$44,000
+46.7%
3,817
+100.7%
0.00%
Q3 2021$30,000
+100.0%
1,902
+143.5%
0.00%
Q2 2021$15,000
-67.4%
781
-27.6%
0.00%
Q1 2021$46,0001,0780.00%
Other shareholders
VOR BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,692,429$124,814,00031.41%
Trustees of Columbia University in the City of New York 183,821$3,428,0005.06%
RA Capital Management 11,120,973$207,406,0003.33%
Johnson & Johnson Innovation - JJDC, Inc. 1,074,658$20,042,0002.05%
Sarissa Capital Management LP 707,010$13,186,0001.05%
SECTORAL ASSET MANAGEMENT INC 405,324$7,559,0000.61%
Woodline Partners LP 1,146,494$21,382,0000.40%
Artal Group S.A. 550,000$10,258,0000.21%
NEXPOINT ASSET MANAGEMENT, L.P. 50,000$933,0000.20%
Orbimed Advisors 833,333$15,542,0000.16%
View complete list of VOR BIOPHARMA INC shareholders